FDA Inspection 984810 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 2176255

The FDA completed an inspection of Biomat USA, Inc. on Sep 9, 2016 in Milwaukee, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 9, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Milwaukee, WI (United States)

Citations

IDCFRDescription
908921 CFR 600.14(c)When to report